Bosch Packaging Technology will present four devices for processing liquid and solid pharmaceutical dosage forms at CPhI Worldwide 2014.

Kurt Lumsden, Director, eCDS Client Services at PAREXEL Informatics, discusses the use of interactive response technologies in investigational product expiry management.

European Commission granted the first biosimilar insulin to receive regulatory approval in Europe.

Asterias Biotherapeutics, Cancer Research UK, and Cancer Research Technology partner for clinical trial of immunotherapy vaccine for the treatment of lung cancer.

FDA approved XTANDI for the treatment of metastatic castration-resistant prostate cancer.

PDA will publish a technical report on quality risk management aspects of drug shortages in early 2015.

Roche?s RoACTEMRA receives EU approval for use in patients with early rheumatoid arthritis.

ProBioGen, a biopharmaceutical drug manufacturer in Berlin, spends ?20 million to double its workforce.

Three-year agreement will support research on treatments for major brain disorders in Neuroscience Catalyst project.

The new China facility will be Merck KGaA's biopharmaceuticals division's second largest worldwide.

The companies plan to develop and commercialize duvelisib (IPI-145).

PDA surveys are designed to evaluate quality metrics practices at member organizations.

Travtec, a packaging line solutions specialist, has opened a second facility close to its Leigh, Lancashire headquarters. This move is part of an investment to expand the company?s operations to meet continuing demand for its systems, particularly as the pharmaceutical industry prepares for the current and forthcoming track and trace legislation, including the 2017 European Falsified Medicines Directive.

DPT Laboratories acquired Media Pharmaceuticals' Lakewood, New Jersey facilities, providing space for aseptic processing suites and filling equipment.

KEYTRUDA was approved for the treatment of unresectable or metastatic melanoma and disease progression.

AbbVie and Calico announce a novel collaboration to accelerate the discovery, development, and commercialization of new therapies.

FDA gives NewLink Genetics approval to proceed to Phase 1 clinical studies of Ebola vaccine.

Catalent's addition of an automated prefilled syringe clinical packaging line at its Philadelphia facility will support its work with Eli Lilly.

Meggle Group Wasserburg has been granted an EXCiPACT certificate.

Conventional tablets may no longer be the go-to solution.

Chinese healthcare reforms may be a double-edged sword for foreign companies.

Industry associations play a strong role in helping the pharmaceutical industry meet challenges.

The National Institute of Allergy and Infectious Diseases will begin the first in a series of trials for an Ebola vaccine during the week of Sept. 1.

ISPE released an advance look at the Introductory Summary of its Drug Shortages Prevention Plan.

FDA found violations of cGMP at finished-drug manufacturer in India.

Concerns about quality in overseas production may bring generic drug production back to the United States, concludes CPhI study.

Consumers warned about products claiming to prevent or treat the Ebola virus.

Cubist Pharmaceuticals voluntarily recalls certain lots of CUBICIN 500 mg in 10 mL single-use vials because of the presence of particulate matter.